Results 161 to 170 of about 2,582,033 (201)
Some of the next articles are maybe not open access.
Topiramate for drug-resistant epilepsies
European Journal of Paediatric Neurology, 2000Topiramate is a new anti-epileptic drug with proven efficacy against partial seizures in adults. A retrospective assessment of the use of topiramate in drug-resistant childhood epilepsy was undertaken. Thirty-four children (median age of 10 years; range 2-18 years) were treated for a median of 9 months (range 6-18 months).
S, Yeung +3 more
openaire +2 more sources
The Preoperative Evaluation of Drug-Resistant Epilepsy
Pediatric Neurology, 2020Antiepileptic drugs afford good seizure control for approximately 70% of individuals with epilepsy. Epilepsy surgery is extremely helpful for appropriate individuals with drug resistance. Since antiquity, trephination was a crude and invasive technique to manage epilepsy.
Dave F, Clarke +2 more
openaire +2 more sources
Ciprofloxacin for treatment of drug-resistant epilepsy
Epilepsy Research, 2021To investigate the efficacy of short-term treatment with ciprofloxacin in alteration of gut microbiota pattern and reduction of seizure frequency in adult patients with drug-resistant epilepsy.In a prospective study, we investigated the effect of a 5-day course of treatment with ciprofloxacin on gut microbiota pattern and seizure frequency of 23 adults
Hamed Cheraghmakani +7 more
openaire +2 more sources
Management of Drug-Resistant Epilepsy
Continuum, 2016This review discusses the definition, evaluation, and management of patients with drug-resistant epilepsy.Drug-resistant epilepsy is defined as a failure of two or more appropriately selected and adequately tried anticonvulsant medications to achieve seizure freedom for a sustained period of time in either monotherapy or polytherapy.
openaire +2 more sources
Genetics of drug resistance in epilepsy
Current Neurology and Neuroscience Reports, 2005Drug resistance is a major clinical problem in epilepsy, affecting one in three patients. It is likely to have a complex multifactorial basis, with environmental and genetic contributions. Knowledge of robust genetic factors underlying drug resistance might both improve prediction and permit the development of novel rational treatments for resistance ...
openaire +2 more sources
Neuroimaging of drug resistance in epilepsy
Current Opinion in Neurology, 2014Drug resistance is an important clinical problem: it is associated with higher rates of somatic and psychiatric comorbidities and cognitive/memory decline, with seizures being just the 'tip of the iceberg'. This review summarizes recent developments in imaging research, focusing specifically on the functional consequence of chronic epilepsies and ...
openaire +2 more sources
Management of Epilepsy in Drug-Resistant Patients
CNS Spectrums, 2010Epilepsy affects > 2 million people in the United States, making it one of the most common neurobiological conditions. Typically, epilepsy is treated with one of several available antiepileptic drugs and patients are able to experience freedom from seizures with minimal side effects.
Brien J, Smith, Andrew J, Cole
openaire +2 more sources
Connectome biomarkers of drug‐resistant epilepsy
Epilepsia, 2020AbstractDrug‐resistant epilepsy (DRE) considerably affects patient health, cognition, and well‐being, and disproportionally contributes to the overall burden of epilepsy. The most common DRE syndromes are temporal lobe epilepsy related to mesiotemporal sclerosis and extratemporal epilepsy related to cortical malformations.
Sara Larivière +3 more
openaire +2 more sources
Identification and Treatment of Drug-Resistant Epilepsy
Continuum, 2019Drug-resistant epilepsy is a potentially life-threatening condition affecting one-third of people living with epilepsy. Despite existing evidence of improved outcomes in patients who received surgical treatment compared to continued medical treatment, epilepsy surgery remains underused in patients with drug-resistant epilepsy.
Ji Yeoun, Yoo, Fedor, Panov
openaire +2 more sources
Neuromodulation in pediatric drug-resistant epilepsy
Epilepsy & BehaviorThis is a summary of the three commercially available neuromodulation devices for refractory epilepsy, highlighting their use in children. The article offers a high-level review of the proposed mechanisms of vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation, the pivotal trials leading to their approval for use in the ...
Ann, Hyslop, Marytery, Fajardo
openaire +2 more sources